Monday, 4 April 2016

Professor Susan Davis announced President Elect of the International Menopause Society

SPHPM's Professor Susan Davis was recently elected to the role of President of the International Menopause Society (IMS). She will serve as President-Elect in the interim and will officially take office at the IMS World Congress in Vancouver in May 2018.

Professor Davis currently serves as a Board member of the IMS and Chair of the Scientific Program Committee for the upcoming IMS World Congress on Menopause in Prague.

She was in Florence to speak at the 17th Congress of the International Society of Gynaecological Endocrinology when she received the news, and will also present at the Endocrine Society's annual meeting in Boston this week.

Professor Davis is a National Health and Medical Research Council of Australia Principal Research Fellow, Chair of Women’s Health and Director of the Women’s Health Research Program at SPHPM.

Professor Davis was recognised for her ground-breaking research in women’s health when she was awarded a prestigious Laureate Award last year by the Endocrine Society for her exceptional contributions to endocrinology.

Her pioneering research has been credited with advancing the understanding of the role of androgens and estrogens in women’s health, as the role of androgens and estrogens encompass numerous aspects of women’s health including breast cancer, cardiovascular function, obesity, cognitive function, mood, sexual function and musculoskeletal health.

She co-established the Jean Hailes Foundation, Australia’s leading women’s health educational organisation, and has been recognised for her work with the Australian Aboriginal community.

In 2015 Professor Davis also led new research at SPHPM on the use and efficacy of complementary and alternative medicines (CAMs) for menopausal symptoms.

The research, the first of its kind in Australia to focus specifically on CAMs and CAM practitioners for the treatment of menopausal symptoms, found that 13 per cent of women aged 40-65 had used at least one CAM for their vasomotor symptoms (VMS) such as hot flushes and night sweats in the previous four weeks to being surveyed. This is similar to the percentage of women of the same age using menopausal hormone therapy (MHT).

Professor Davis is now working with a task force, via invitation from the Clinical Guidelines Subcommittee of the Endocrine Society, to develop evidence-based recommendations for menopause. She said that health care providers need to actively guide women in the management of VMS and other menopausal symptoms.

SPHPM congratulates Professor Davis on this important and duly deserved appointment, and for her continued dedication to women’s health research.

No comments:

Post a Comment

linkwithin

Related Posts Plugin for WordPress, Blogger...